Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M.
Progress in Clinical and Biological Research 382: 359-364
1993
ISSN/ISBN: 0361-7742 PMID: 8502704 Document Number: 414315
Document emailed within 1 workday
Related Documents
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Bresci, G.; Parisi, G.; Banti, S.; Bertoni, M. 1993: Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up European Journal of Medicine 2(6): 349-352
Li, X.; Cui, Z.; Zhang, F. 1999: A report of recombinant interferon-alpha therapy in 19 patients with acute hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 13(3): 295-297
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Niederau, C.; Heintges, T.; Niederau, M.; Stremmel, W.; Strohmeyer, G. 1993: Selection of patients with chronic hepatitis B for therapy with alpha-interferon Zeitschrift für Arztliche Fortbildung 87(4): 273-278
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Marinucci, G.; Hassan, G.; Di Giacomo, C.; Barlattani, A.; Costa, F.; Rasshofer, R.; Roggendorf, M. 1991: Long term treatment of chronic delta hepatitis with alpha recombinant interferon Progress in Clinical and Biological Research 364: 405-410
Carreño, V.; Porres, J.C.; Ruiz-Moreno, M.; Gutiez, J.; Bartolomé, F.J. 1991: A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(1): 24-28
El-Zayadi, A.; Osaima, S.; Haseeb, N.; Dabbous, H. 1995: Controlled trial with human lymphoblastoid interferon among HBeAg and anti-HBe-positive chronic hepatitis B patients in Egypt Journal of the Egyptian Public Health Association 70(5-6): 579-594
Lönnqvist, B.; Brune, M.; Ljungman, P. 1996: Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report Bone Marrow Transplantation 18(1): 241-242
Utili, R.; Sagnelli, E.; Galanti, B.; Aprea, L.; Cesaro, G.; Digilio, L.; Filippini, P.; Felaco, F.M.; Gaeta, G.B.; Marrone, A. 1991: Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study American Journal of Gastroenterology 86(3): 327-330
Perrillo, R.P.; Regenstein, F.G.; Peters, M.G.; DeSchryver-Kecskemeti, K.; Bodicky, C.J.; Campbell, C.R.; Kuhns, M.C. 1988: Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial Annals of Internal Medicine 109(2): 95-100
Rostaing, L.; Izopet, J.; Baron, E.; Duffaut, M.; Puel, J.; Durand, D. 1995: Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects Transplantation Proceedings 27(1): 948-950
Fujisawa, T.; Inui, A.; Komatsu, H.; Miyagawa, Y.; Onoue, M. 1998: Interferon-alpha therapy for children with chronic hepatitis C Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 39(3): 146-149
Jurincic-Winkler, C.; Horlbeck, R.; Klippel, K.F. 1993: Combination therapy with recombinant interferon alpha-21 (rIFN alpha 2a) and recombinant interleukin 2 (rIL-2) in metastatic renal cell cancer Wiener Klinische Wochenschrift 105(10): 271-276
Alscher, D.M.; Bode, J.C. 1992: Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha Medizinische Klinik 87(10): 532-539
Gaudin, J.L.; Trépo, C. 1993: Therapy of chronic delta hepatitis with alpha- and beta-interferon Progress in Clinical and Biological Research 382: 345-352
Zuberi, S.J.; Alam, S.E.; Raza, S. 1994: Interferon alpha 2a in patients of chronic hepatitis C Jpma. Journal of the Pakistan Medical Association 44(7): 171-172